Patents Represented by Attorney Johnson & Johnson
-
Patent number: 8292256Abstract: This invention describes molds made from alicyclic co-polymers that are useful in the production of contact lenses and methods for their use.Type: GrantFiled: September 22, 2010Date of Patent: October 23, 2012Assignee: Johnson & Johnson Vision Care, Inc.Inventors: Changhong Yin, Scott F. Ansell
-
Patent number: 8281920Abstract: The invention provides contact lens packages in which removal of the lens is facilitated by providing a means for elevating the lens when the package is opened.Type: GrantFiled: April 1, 2010Date of Patent: October 9, 2012Assignee: Johnson & Johnson Vision Care, Inc.Inventors: Michael G. Tokarski, James Peck, Edward Dzwill, George Brock, Roger W. Smith, Michael D. Schulte, Michael Scott Ulrich
-
Patent number: 8183353Abstract: A method of providing a prognosis of breast cancer is conducted by analyzing the expression of a group of genes. Gene expression profiles in a variety of medium such as microarrays are included as are kits that contain them.Type: GrantFiled: October 25, 2007Date of Patent: May 22, 2012Assignee: Veridex, LLC.Inventor: Yixin Wang
-
Patent number: 8138198Abstract: This invention comprises the novel compounds of formula (I) wherein R1, R2, R3, R4, X and Y have defined meanings, having histone deacetylase inhibiting enzymatic activity; their preparation, compositions containing them and their use as a medicine.Type: GrantFiled: May 16, 2006Date of Patent: March 20, 2012Inventors: Patrick René Angibaud, Laurence Françoise Bernadette Marconnet-Decrane, Sven Franciscus Anna Van Brandt, Isabelle Noëlle Constance Pilatte
-
Patent number: 8119650Abstract: This invention comprises the novel compounds of formula (I) wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, X and Y have defined meanings, having histone deacetylase inhibiting enzymatic activity; their preparation, compositions containing them and their use as a medicine.Type: GrantFiled: January 16, 2007Date of Patent: February 21, 2012Assignee: Janssen Pharmaceutica N.V.Inventors: Patrick René Angibaud, Isabelle Noëlle Constance Pilatte, Bruno Roux, Janine Arts
-
Patent number: 8114999Abstract: This invention comprises the novel compounds of formula (I) wherein n, R1, R2, R3, R4, L, Q, X, Y, Z and have defined meanings, having histone deacetylase inhibiting enzymatic activity; their preparation, compositions containing them and their use as a medicine.Type: GrantFiled: January 27, 2009Date of Patent: February 14, 2012Assignee: Janssen Pharmaceutica N.V.Inventors: Kristof Van Emelen, Hans Louis Jos De Winter, Alexy Borisovich Dyatkin, Marc Gustaaf Celine Verdonck, Lieven Meerpoel, Jimmy Arnold Viviane Van heusden
-
Patent number: 8114876Abstract: This invention comprises the novel compounds of formula (I) wherein R1, R2, R3 and X have defined meanings, having histone deacetylase inhibiting enzymatic activity; their preparation, compositions containing them and their use as a medicine.Type: GrantFiled: January 16, 2007Date of Patent: February 14, 2012Assignee: Janssen Pharmaceutica N.V.Inventors: Laurence Françoise Bernadette Marconnet-Decrane, Sandrine Françoise Dominique Gaurrand, Patrick René Angibaud
-
Patent number: 8101616Abstract: This invention comprises the novel compounds of formula (I) wherein R1, R2, R3, R4, R5, R6, R7, R8, R9 and X have defined meanings, having histone deacetylase inhibiting enzymatic activity; their preparation, compositions containing them and their use as a medicine.Type: GrantFiled: January 16, 2007Date of Patent: January 24, 2012Assignee: Janssen Pharmaceutica N.V.Inventors: Patrick René Angibaud, Laurence Françoise Bernadette Marconnet-Decrane, Janine Arts
-
Patent number: 8030318Abstract: Substituted fused bicyclic pyrimidine compounds having an amide-substituted pyridylamine group at C-4 of the pyrimidine ring are useful in the treatment of conditions associated with HCV.Type: GrantFiled: March 27, 2006Date of Patent: October 4, 2011Assignee: Tibotec Pharmaceuticals Ltd.Inventors: Kenneth Alan Simmen, Dominique Louis Nestor Ghislain Surleraux, Tse-I Lin, Oliver Lenz, Pierre Jean-Marie Bernard Raboisson, Sarvajit Chakravarty, Barry Patrick Hart
-
Patent number: 8013153Abstract: The present invention is directed to substituted pyrimidine compounds of formula (I): and forms thereof, their synthesis and use for treating a chronic or acute protein kinase mediated disease, disorder or condition.Type: GrantFiled: March 23, 2007Date of Patent: September 6, 2011Assignee: Janssen Pharmaceutica, N.V.Inventors: Jeannene Butler, Peter J. Connolly, Angel R. Fuentes-Pesquera, Lee M. Greenberger, Shenlin Huang, Kenneth R. LaMontagne, Jr., Ronghua Li, Guozhang Xu
-
Patent number: 7950956Abstract: A ready to use tracer wire connector kit comprising a pod and cover that can be mated together around a tracer wire connector that can be retained in the pod or removed from the pod as the tracer wires are joined therein with the pod and cover encapsulating and protecting the junction of tracer wires in the tracer wire connector and a method and system wherein underground difficult to detect devices and systems can be indirectly located.Type: GrantFiled: April 2, 2008Date of Patent: May 31, 2011Assignee: The Patent Store LLCInventors: William Hiner, James C. Keeven, Lloyd Herbert King, Jr.
-
Patent number: 7764821Abstract: The enumeration of cells in fluids by flow cytometry is widely used across many disciplines such as assessment of leukocyte subsets in different bodily fluids or of bacterial contamination in environmental samples, food products and bodily fluids. For many applications the cost, size and complexity of the instruments prevents wider use, for example, CD4 analysis in HIV monitoring in resource-poor countries. The novel device, methods and algorithms disclosed herein largely overcome these limitations. Briefly, all cells in a biological sample are fluorescently labeled, but only the target cells are also magnetically labeled. In addition, non-magnetically labeled cells are imaged for viability in a modified slide configuration. The labeled sample, in a chamber or cuvet, is placed between two wedge-shaped magnets to selectively move the magnetically labeled cells to the observation surface of the cuvet.Type: GrantFiled: May 12, 2006Date of Patent: July 27, 2010Assignee: Veridex, LLCInventors: Frank A. W. Coumans, Jan Greve, Frank P. Modica, Leon W. M. M. Terstappen, Arjan G. J. Tibbe, John A. Verrant
-
Patent number: 7425466Abstract: A semiconductor package wire bonding system and method of use are provided. The wire bonding system includes a heating block that heats and supports a printed circuit board on which a multi-layered semiconductor chip structure having an overhang is mounted. A support inserted through an opening in the printed circuit board supporting the overhang portion of the semiconductor chip structure is installed in a predetermined region of the heating block. Multiple supports on the heating block may support overhand portions on multiple semiconductor chip structures.Type: GrantFiled: February 27, 2007Date of Patent: September 16, 2008Assignee: Samsung Electronics Co., LtdInventor: Won-Chul Lim
-
Patent number: 6962916Abstract: This invention concerns the compounds of formula the pharmaceutically acceptable acid addition salts and the stereochemically isomeric forms thereof, wherein R1 and R2 are each independently selected from hydrogen; hydroxy; amino; optionally substituted C1-6alkyl; C1-6alkyloxy; C1-6alkylcarbonyl; C1-6alkyloxycarbonyl; Ar1; mono- or di(C1-6alkyl)amino; mono- or di(C1-6alkyl)aminocarbonyl; dihydro-2(3H)-furanone; or R1 and R2 taken together may form pyrrolidinyl, piperidinyl, morpholinyl, azido or mono- or di(C1-6alkyl)amino-C1-4alkylidene; R3 is hydrogen, Ar1, C1-6alkylcarbonyl, C1-6alkyl, C1-6alkyloxycarbonyl, C1-6alkyl substituted with C1-6alkyloxycarbonyl; and R4, R5, R6, R7 and R8 are each independently selected from hydrogen, halo, C1-6alkyl, C1-6alkyloxy, cyano, aminocarbonyl, nitro, amino, trihalomethyl or trihalomethyloxy; L is optionally substituted C1-10alkyl; C3-10alkenyl; C3-10alkynyl; C3-7cycloalkyl; Ar1 is optionally substituted phenyl; for the manufacture of a medicine for the treatment of sType: GrantFiled: March 26, 2003Date of Patent: November 8, 2005Assignee: Janssen Pharmaceutica N.V.Inventors: Paul A. J. Janssen, Jan Heeres, Henri E. L. Moereels, Michael Joseph Kukla, Donald W. Ludovici
-
Patent number: 6694504Abstract: The present invention, by improving the silicon surface/bulk micromachining technology using two steps of silicon etch mask patterning and four steps of silicon etching, fabricates a structure which has vertically offset electrodes and consequently fabricates an electrostatic vertical and torsional actuator using one single-crystalline silicon wafer. According to the method of the present invention, the problems of the prior art that used a number of silicon wafers and single/double SOI wafers, or combining of these wafers with additional deposited poly-crystalline silicon films, may be resolved.Type: GrantFiled: May 6, 2002Date of Patent: February 17, 2004Inventors: Dong-il Cho, Jongpal Kim
-
Patent number: 6182594Abstract: An innertube accessory that facilitates towing an innertube by a boat. The accessory includes a shell for receiving any size innertube and attaching it. The accessory is suitable for being towed by the boat, by a track and trolley mechanism that adapts to different towing angles away from the boat center line. The innertube rider can steer the accessory by operating a rudder. The rudder is a steering rope that controls pivoting of a rudder fin relative to the shell. Additional fins provide stability.Type: GrantFiled: October 12, 1999Date of Patent: February 6, 2001Inventor: Charles G. Wilson